BUSINESS BRIEFING / PHARMACEUTICALS
TIMES WIRE REPORTS
Pfizer Inc. won preliminary approval for an $89-million settlement resolving claims over marketing of the Bextra and Celebrex prescription drugs.
If final approval of the settlement is given Sept. 25, the money would go to consumers and insurance companies or other entities that paid for either painkiller before July 29, 2005, the claims administrator said in a statement.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
